Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock waves or magnetic fields: which eases knee pain better?

NCT ID NCT07505368

Symptom relief Sponsor: Suez Canal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two treatments—shock wave therapy and pulsed electromagnetic field therapy—in 60 people with mild to moderate knee osteoarthritis. The goal was to see which one better reduces pain, improves daily function, and increases knee movement. Participants were aged 40 to 60 and had knee pain for over three months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Sixty patients must have a confirmed diagnosis of knee osteoarthritis, specifically those with mild to moderate osteoarthritis. 2. Participants must have experienced knee pain lasting more than 3 months. 3. Their ages will be ranged from 40 to 60 years. 4. Their body mass index within the range of 22.7 to 28.5 kg/m² kg/m². 5. Both male and female patients are eligible for the study. 6. At least two positive provocative tests, such as joint line tenderness and crepitus, which are commonly associated with knee osteoarthritis. Exclusion Criteria: 1. Inflammatory arthritis (e.g., rheumatoid arthritis) or other forms of arthritis that are not osteoarthritis. 2. Undergone knee replacement surgery or any significant knee surgery within the past year. 3. Severe cardiovascular, respiratory, renal, or hepatic diseases that could interfere with study participation or outcomes. 4. Received intra-articular corticosteroid injections in the affected knee within the last 3 months. 5. Pregnant or breastfeeding due to the unknown effects of study treatments on fetal and infant development. 6. Neurological conditions affecting the lower limbs (e.g., stroke, neuropathy). body mass index greater than 30 kg/m², as severe obesity may influence treatment outcomes and complicate assessment. 7. Cognitive impairments or psychiatric conditions that may affect their ability to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Physical therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Physical therapy

Contacts and locations

Locations

  • The Outpatient Clinics, Faculty of Physical Therapy Suez Canal University

    Ismailia, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.